Nanoprecipitation and the "Ouzo effect": Application to drug delivery devices

Advanced Drug Delivery Reviews

Volumn 71, Issue , 2014, Pages 86-97

  Lepeltier, Elise ^a   Bourgaux, Claudie ^a   Couvreur, Patrick ^a  

^a UNIV PARIS SUD   (France)

Author keywords

Nanoparticles; Nanoprecipitation; Nucleation and growth; Ouzo effect; Squalenoylation; Terpenoid prodrug

Indexed keywords

BIODEGRADABLE POLYMERS; DRUG DELIVERY; DRUG INTERACTIONS; HYDROPHOBICITY; LIPIDS;

NANO PRECIPITATIONS; NUCLEATION AND GROWTH; OUZO EFFECT; PRODRUGS; SQUALENOYLATION;

NANOPARTICLES;

GEMCITABINE; LIPID; NANOCAPSULE; NANOCARRIER; NANOPARTICLE; PACLITAXEL; PENICILLIN G; POLYGLACTIN; POLYMER; PRODRUG; TERPENOID; DRUG CARRIER; SOLVENT;

ANTINEOPLASTIC ACTIVITY; CHOLESTEROL SYNTHESIS; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; EMULSION; HUMAN; HYDROPHOBICITY; KINETICS; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW; CHEMICAL PHENOMENA; CHEMISTRY; DRUG DESIGN; MEDICINAL CHEMISTRY; PRECIPITATION;

CHEMICAL PRECIPITATION; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LIPIDS; NANOPARTICLES; PARTICLE SIZE; POLYMERS; SOLVENTS;

EID: 84901400939     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2013.12.009     Document Type: Review

References (85)

1. Allen T.M., Cullis P.R. Drug delivery systems: entering the main stream. Science 2004, 303:1818-1822.
2. Nicolas J., Mura S., Brambilla D., Mackiewicz N., Couvreur P. Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. Chem. Soc. Rev. 2013, 42:1147-1235.
3. Soussan E., Cassel S., Blanzat M., Rico-Lattes I. Drug delivery by soft matter: matrix and vesicular carriers. Angew. Chem. 2009, 48:274-288.
4. Vauthier C., Couvreur P. Nanomedicines: a new approach for the treatment of serious diseases. J. Biomed. Nanotechnol. 2007, 3:1-12.
5. Brannon-Peppas L., Blanchette J.O. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 2004, 56:1649-1659.
6. Panyam J., Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 2003, 55:329-347.
7. Kataoka K., Harada A., Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv. Drug Deliv. Rev. 2001, 47:113-131.
8. Hillaireau H., Couvreur P. Nanocarriers' entry into the cell: relevance to drug delivery. Cell. Mol. Life Sci. 2009, 66:2873-2896.
9. Lee H., Fonge H., Hoang B., Reilly R.M., Allen C. The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles. Mol. Pharm. 2010, 7:1195-1208.
10. Lu F., Wu S.H., Hung Y., Mou C.Y. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticle. Small 2009, 5:1408-1413.
11. Simone E.A., Dziubla T.D., Muzykantov V.R. Polymeric carriers: role of geometry in drug delivery. Expert Opin. Drug Deliv. 2008, 5:1283-1300.
12. Hühn D., Kantner K., Geidel C., Brandholt S., De Cock I., Soenen S.J.H., Rivera-Gil P., Montenegro J.M., Braeckmans K., Müllen K., Nienhaus G.U., Klapper M., Parak W.J. Polymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net charge. ACS Nano 2013, 7:3253-3263.
13. Dobrovolskaia M.A., Aggarwal P., Hall J.B., McNeil S.E. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol. Pharm. 2008, 5:487-495.
14. Qiu Y., Liu Y., Wang L., Xu L., Bai R., Ji Y., Wu X., Zhao Y., Li Y., Chen C. Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials 2010, 31:7606-7619.
15. Decuzzi P., Pasqualini R., Arap W., Ferrari M. Intravascular delivery of particulate systems: does geometry really matter?. Pharm. Res. 2009, 26:235-243.
16. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 2000, 65:271-284.
17. Maeda H. Macromolecular therapeutics in cancer treatment: the EPR effect and beyond. J. Control. Release 2012, 164:138-144.
18. Yuan F., Dellian M., Fukumura D., Leuning M., Berk D.D., Yorchilin V.P., Jain R.K. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 1995, 55:3752-3756.
19. Torchilin V.P. Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J. 2007, 9. (article 15).
20. Vauthier C., Bouchemal K. Methods for the preparation and manufacture of polymeric nanoparticles. Pharm. Res. 2009, 26:1025-1056.
21. Galindo-Rodriguez S., Alleman E., Fessi H., Doelker E. Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm. Res. 2004, 21:1428-1439.
22. Mora-Huertas C.E., Fessi H., Elaissari A. Influence of process and formulation parameters on the formation of submicron particles by solvent displacement and emulsification-diffusion methods. Critical comparison. Adv. Colloid Interf. Sci. 2011, 163:90-122.
23. Vitale S.A., Katz J.L. Liquid droplet dispersions formed by homogeneous liquid-liquid nucleation: "the Ouzo effect". Langmuir 2003, 19:4105-4110.
24. Ganachaud F., Katz J.L. Nanoparticles and nanocapsules created using the Ouzo effect: spontaneous emulsification as an alternative to ultrasonic and high-shear devices. ChemPhysChem 2005, 9:209-216.
25. Horn D., Rieger J. Organic nanoparticles in aqueous phase. Angew. Chem. 2001, 40:4330-4361.
26. Aubry J., Ganachaud F., Cohen-Addad J.P., Cabane B. Nanoprecipitation of polymethylmethacrylate by solvent shifting: 1. Boundaries. Langmuir 2009, 25:1970-1979.
27. Watzky M.A., Finke R.G. Transition metal nanocluster formation kinetic and mechanistic studies. A new mechanism when hydrogen is the reductant: slow, continuous nucleation and fast autocatalytic surface growth. J. Am. Chem. Soc. 1997, 119:10382-10400.
28. Han J., Testard F., Maloggi F., Coulon P.E., Menguy N., Spalla O. Understanding of the size control of biocompatible gold nanoparticles in millifluidic channels. Langmuir 2012, 28:15966-15974.
29. Matijevic E. Uniform inorganic colloid dispersions. Achievements and challenges. Langmuir 1994, 10:8-16.
30. Polte J., Ahner T.T., Delissen F., Sokolov S., Emmerling F., Thünemann A.F., Kraehnert R. Mechanism of gold nanoparticle formation in the classical citrate synthesis method derived from coupled in situ XANES and SAXS evaluation. J. Am. Chem. Soc. 2010, 132:1296-1301.
31. Polte J., Erler R., Thünemann A.F., Sokolov S., Ahner T.T., Rademann K., Emmerling F., Kraehnert R. Nucleation and growth of gold nanoparticles studied via in situ small angle X-ray scattering at millisecond time resolution. ACS Nano 2010, 4:1076-1082.
32. Liu Y., Kathan K., Saad W., Prud'homme R.K. Ostwald ripening of β-carotene nanoparticles. Phys. Rev. Lett. 2007, 98:036102.
33. Botet R. The "Ouzo effect", recent developments and application to therapeutic drug carrying. J. Phys. Conf. Ser. 2012, 352:1-8.
34. Carteau D., Pianet I., Brunerie P., Guillemat B., Bassani D.M. Probing the initial events in the spontaneous emulsification of trans-anethole using dynamic NMR spectroscopy. Langmuir 2007, 23:3561-3565.
35. Carteau D., Bassani D., Pianet I. The «Ouzo effect»: following the spontaneous emulsification of trans-anethole in water by NMR. C.R. Chim. 2008, 11:493-498.
36. Grillo I. Small-angle neutron scattering study of a world-wide known emulsion: Le Pastis. Colloids Surf., A 2003, 225:153-160.
37. Sitnikova N.L., Sprik R., Wegdam G., Eiser E. Spontaneously formed trans-anethol/water/alcool emulsions: mechanism of formation and stability. Langmuir 2005, 21:7083-7089.
38. Scholten E., van der Linden E., This H. The life of an anise flavored alcoholic beverage: does its stability cloud or confirm theory?. Langmuir 2008, 24:1701-1706.
39. Kumar V., Prud'homme R.K. Nanoparticle stability: processing pathways for solvent removal. Chem. Eng. Sci. 2009, 64:1358-1361.
40. Johnson B.K., Prud'homme R.K. Mechanism for rapid self-assembly of block copolymer nanoparticles. Phys. Rev. Lett. 2003, 91:118302.
41. Hiemenz P.C., Rajagopalan R. Principles of Colloid and Surface Chemistry 1997, Marcel Dekker Inc., New York. 3rd edition.
42. Roger K., Botet R., Cabane B. Coalescence of repelling colloidal droplets: a route to monodisperse populations. Langmuir 2013, 29:5689-5700.
43. Zhu Z., Margulis-Goshen K., Magdassi S., Talmon Y., Macosko C.W. Polyelectrolyte stabilized drug nanoparticles via flash nanoprecipitation: a model study with β-carotene. J. Pharm. Sci. 2010, 99:4295-4306.
44. Zhu Z. Effects of amphiphilic diblock copolymer on drug nanoparticle formation and stability. Biomaterials 2013, 34:10238-10248.
45. Lannibois H., Hasmy A., Botet R., Aguerre Charriol O., Cabane B. Surfactant limited aggregation of hydrophobic molecules in water. J. Phys. II France 1997, 7:319-342.
46. Upadhyay K.K., Bhatt A.N., Mishra A.K., Dwarakanath B.S., Jain S., Schatz C., Le Meins J.F., Farooque A., Chandraiah G., Jain A.K., Misra A., Lecommandoux S. The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(gamma-benzyl L-glutamate)-b-hyaluronan polymersomes. Biomaterials 2010, 31:2882-2892.
47. Campardelli R., Della Porta G., Reverchon E. Solvent elimination from polymer nanoparticle suspensions by continuous supercritical extraction. J. Supercrit. Fluids 2012, 70:100-105.
48. d'Addio S.M., Prud'homme R.K. Controlling drug nanoparticle formation by rapid precipitation. Adv. Drug Deliv. Rev. 2011, 63:417-426.
49. Karnik R., Gu F., Basto P., Cannizaro C., Dean L., Kyei-Manu W., Langer R., Farokhzad O.C. Microfluidic platform for controlled synthesis of polymeric nanoparticles. Nano Lett. 2008, 8:2906-2912.
50. Johnson B.K., Prud'homme R.K. Chemical processing and micromixing in confined impinging jets. AIChE J. 2003, 49:2264-2282.
51. Liu Y., Fox R.O. CFD predictions for chemical processing in a confined impinging-jets reactor. AIChE J. 2006, 52:731-744.
52. Bally F., Garg D.K., Serra C.A., Hoarau Y., Anton N., Brochon C., Parida D., Vandamme T., Hadziioannou G. Improved size-tunable preparation of polymeric nanoparticles by microfluidic nanoprecipitation. Polymer 2012, 53:5045-5051.
53. Molpeceres J., Guzman M., Arberturas M.R., Chacon M., Berges L. Application of central composite designs to the preparation of polycaprolactone nanoparticles by solvent displacement. J. Pharm. Sci. 1996, 85:206-213.
54. Abecassis B., Testard F., Spalla O., Barboux P. Probing in situ the nucleation and growth of gold nanoparticles by small-angle X-ray scattering. Nano Lett. 2007, 7:1723-1727.
55. Brick M.C., Palmer H.J., Whitesides T.H. Formation of colloidal dispersions of organic materials in aqueous media by solvent shifting. Langmuir 2003, 19:6367-6380.
56. Haberkorn H., Franke D., Frechen Th., Goesele W., Rieger J. Early stages of particle formation in precipitation reactions - quinacridone and boehmite as generic examples. J. Colloid Interface Sci. 2003, 259:112-126.
57. Fessi H., Puisieux F., Devissaguet J.P., Ammoury N., Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm. 1989, 55:R1-R4.
58. Thioune O., Fessi H., Devissaguet J.P., Puisieux F. Preparation of pseudolatex by nanoprecipitation: influence of the solvent nature on intrinsic viscosity and interaction constant. Int. J. Pharm. 1997, 146:233-238.
59. Stainmesse S., Orecchioni A.-M., Nakache E., Puisieux F., Fessi H. Formation and stabilization of a biodegradable polymeric colloidal suspension of nanoparticles. Colloid Polym. Sci. 1995, 273:505-511.
60. Beck-Broichsitter M., Rytting E., Lebhardt T., Wang X., Kissel T. Preparation of nanoparticles by solvent displacement for drug delivery: a shift in the "Ouzo region" upon drug loading. Eur. J. Pharm. Sci. 2010, 41:244-253.
61. Legrand P., Lesieur S., Bochot A., Gref R., Raatjes W., Barratt G., Vauthier C. Influence of polymer behaviour in organic solution on the production of polylactide nanoparticles by nanoprecipitation. Int. J. Pharm. 2007, 344:33-43.
62. Stepanyan R., Lebouille J.G.J.L., Slot J.J.M., Tuinier R., Cohen Stuart M.A. Controlled nanoparticle formation by diffusion limited coalescence. Phys. Rev. Lett. 2012, 109:138301.
63. Cheng J., Teply B.A., Sherifi I., Sung J., Luther G., Gu F.X., Levy-Nissenbaum E., Radovic-Moreno A.F., Langer R., Farokhzad O.C. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials 2007, 28:869-876.
64. Lund R., Willner L., Monkenbusch M., Panine P., Narayanan T., Colmenero J., Richter D. Structural observation and kinetic pathway in the formation of polymeric micelles. Phys. Rev. Lett. 2009, 102:188301.
65. Nicolai T., Colombani O., Chassenieux C. Dynamic polymeric micelles versus frozen nanoparticles formed by block copolymers. Soft Matter 2010, 6:3111-3118.
66. Kumar V., Wang L., Riebe M., Tung H.H., Prud'homme R.K. Formulation and stability of Itraconazole and Odanacatib nanoparticles: governing physical parameters. Mol. Pharm. 2009, 6:1118-1124.
67. Riley T., Stolnik S., Heald C.R., Xiong C.D., Garnett M.C., Illum L., Davis S.S., Purkiss S.C., Barlow R.J., Gellert P.R. Physicochemical evaluation of nanoparticles assembled from poly(lactic acid)-poly(ethylene glycol) (PLA-PEG) block copolymers as drug delivery vehicles. Langmuir 2001, 17:3168-3174.
68. Zhu Z., Anacker J.L., Ji S., Hoye T.R., Macosko C.W., Prud'homme R.K. Formation of block copolymer-protected nanoparticles via reactive impingement mixing. Langmuir 2007, 23:10499-10504.
69. Gaucher G., Marchessault R.H., Leroux J.C. Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes. J. Control. Release 2010, 143:2-12.
70. Bilati U., Allemann E., Doelker E. Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs in nanoparticles. Eur. J. Pharm. Sci. 2005, 24:67-75.
71. Le Droumaguet B., Nicolas J., Brambilla D., Mura S., Maksimenko A., De Kimpe L., Salvati E., Zona C., Airoldi C., Canovi M., Gobbi M., Noiray M., La Ferla B., Nicotra F., Scheper W., Flores O., Masserini M., Andrieux K., Couvreur P. Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer's disease. ACS Nano 2012, 6:5866-5879.
72. Discher B.M., Won Y.Y., Ege D.S., Lee J.C.M., Bates F.S., Discher D.E., Hammer D.A. Polymersomes: though vesicles made from diblock copolymers. Science 1999, 284:1143-1146.
73. Discher D.E., Eisenberg A. Polymer vesicles. Science 2002, 297:967-973.
74. Bui L., Abbou S., Ibarboure E., Guidolin N., Staedel C., Toulme J.J., Lecommandoux S., Schatz C. Encapsidation of RNA-polyelectrolyte complexes with amphiphilic block copolymers: toward a new self-assembly route. J. Am. Chem. Soc. 2012, 134:20189-20196.
75. Joralemon M.J., McRae S., Emrick T. PEGylated polymers for medicine: from conjugation to self-assembled systems. Chem. Commun. 2010, 46:1377-1393.
76. Couvreur P., Stella B., Reddy L.H., Hillaireau H., Dubernet C., Desmaële D., Lepêtre-Mouelhi S., Rocco F., Dereudre-Bosquet N., Clayette P., Rosilio V., Marsaud V., Renoir J.M., Cattel L. Squalenoyl nanomedicines as potential therapeutics. Nano Lett. 2006, 6:2544-2548.
77. Couvreur P., Reddy L.H., Mangenot S., Poupaert J.H., Desmaële D., Lepêtre-Mouelhi S., Pili B., Bourgaux C., Amenitsch H., Ollivon M. Discovery of new hexagonal supramolecular nanostructures formed by squalenoylation of an anticancer nucleoside analogue. Small 2008, 4:247-253.
78. Allain V., Bourgaux C., Couvreur P. Self-assembled nucleolipids: from supramolecular structure to soft nucleic acid and drug delivery devices. Nucleic Acids Res. 2012, 40:1891-1903.
79. Lepeltier E., Bourgaux C., Rosilio V., Poupaert J.H., Meneau F., Zouhiri F., Lepêtre-Mouelhi S., Desmaële D., Couvreur P. Self-assembly of squalene-based nucleolipids: relating the chemical structure of the bioconjugates to the architecture of the nanoparticles. Langmuir 2013, 29:14795-14803.
80. Bekkara-Aounallah F., Gref R., Othman M., Reddy L.H., Pili B., Allain V., Bourgaux C., Hillaireau H., Lepêtre-Mouelhi S., Desmaële D., Nicolas J., Chafi N., Couvreur P. Novel PEGylated nanoassemblies made of self-assembled squalenoyl nucleoside analogues. Adv. Funct. Mater. 2008, 18:3715-3725.
81. Caron J., Maksimenko A., Wack S., Lepeltier E., Bourgaux C., Morvan E., Leblanc K., Couvreur P., Desmaele D. Improving the antitumoractivity of squalenoyl-paclitaxel conjugate nanoassemblies by manipulating the linker between paclitaxel and squalene. Adv. Healthc. Mater. 2013, 2:172-185.
82. Semiramoth N., Di Meo C., Zouhiri F., Saïd-Hassane F., Valetti S., Gorges R., Nicolas V., Poupaert J.H., Chollet-Martin S., Desmaële D., Gref R., Couvreur P. Self-assembled penicillin bioconjugates: an original approach for the treatment of intracellular infections. ACS Nano 2012, 6:3820-3831.
83. Maksimenko A., Mougin J., Mura S., Sliwinski E., Lepeltier E., Bourgaux C., Lepêtre S., Zouhiri F., Desmaële D., Couvreur P. Polyisoprenoyl gemcitabine conjugates self-assemble as nanoparticles, useful for cancer therapy. Cancer Lett. 2013, 334:346-353.
84. Harrisson S., Nicolas J., Maksimenko A., Bui D.T., Mougin J., Couvreur P. Nanoparticles with in vivo anticancer activity from polymer prodrug amphiphiles prepared by living radical polymerization. Angew. Chem. 2013, 52:1678-1682.
85. Arias J.L., Reddy L.H., Othman M., Gillet B., Desmaële D., Zouhiri F., Dosio F., Gref R., Couvreur P. Squalene-based nanocomposites: a new platform for the design of multifunctional pharmaceutical theragnostics. ACS Nano 2011, 5:1513-1521.